Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Vertical Pharmaceuticals, Inc.
WARNING LETTER
•Vertical Pharmaceuticals, Inc.

Vertical Pharmaceuticals, Inc. – FDA Warning Letter

Record Details

This FDA Warning Letter, dated (b)(4), was issued to Vertical Pharmaceuticals, Inc. concerning drug products, specifically (b)(4), manufactured by (b)(4) under contract. The FDA had previously warned (b)(4) about unapproved new drugs. The product (b)(4) is identified as a "new drug" under section 201(p) of the Act, lacking FDA-approved applications required by sections 301(d) and 505(a). Its introduction into interstate commerce without approval violates sections 301(a) and (d) of the Act. Additionally, the product's labeling fails to bear adequate directions for use, causing it to be misbranded under section 502(f)(1) of the Act, as it is not exempt per 21 C.F.R. § 201.115. The drug product is also deemed adulterated under 21 U.S.C. 351(a)(2)(B). Vertical Pharmaceuticals is responsible for investigating and correcting these violations, which may apply to all unapproved drug products they market. The firm must notify FDA within fifteen working days of specific corrective actions, recurrence prevention steps, and supporting documentation. Failure to comply may result in legal action, including seizure and injunction, and could impact future federal contracts.

Company
Vertical Pharmaceuticals, Inc.
Product type
Devices
Office
New Jersey District Office
Person
  • Diana Amador-Toro (District Director)
View Company Profile

ID · a454d8d8-14a1-420a-8a1b-05bbdf240618

Violation Codes10
21 U.S.C. 321(g)21 U.S.C. 351(a)(2)(B)21 U.S.C. 331(a)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 355(b)21 U.S.C. 352(f)(1)21 CFR 201.521 CFR 201.115

Full citation text and observation details available on the Dashboard.

Other documents for Vertical Pharmaceuticals, Inc.
  • CRL

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Vertical Pharmaceuticals, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.